PAD: Clinical Trials

4 trials for PAD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 1, Unknown 1
Phase 12Completed 1, Unknown 1

Follow PAD: new trials by email Literature Review of PAD trials Research Report on PAD

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Micro-mobile Foot Compression and Diabetic Foot
Avex Footbeat - Diabetes, PAD
Phase 2CompletedBaylor College of Medicine302017-05-022021-10-28
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
unacelyated ghrelin - Peripheral Artery Disease, PAD
Phase 1 / Phase 2CompletedNorthwestern University92016-06-072020-03-12
European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)
Cotavance Paclitaxel Coated Balloon, Standard balloon angioplasty - PAD, Infrapopliteal Lesions
Phase 2TerminatedBayer442011-08-152024-01-30
Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)
MultiGeneAngio - PAD, Claudication
Phase 1 / Phase 2UnknownMultiGene Vascular Systems Ltd.122006-10-012015-03-05

Narrower conditions

Peripheral Arterial Disease (2)  ·  Diabetes Mellitus (1)  ·  Diabetic Foot (1)  ·  Intermittent Claudication (1)  ·  Lymphatic Diseases (1)  ·  Neuritis (1)  ·  Peripheral Vascular Diseases (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Vascular Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Atherosclerosis (2)  ·  Diabetes Complications (1)  ·  Diabetic Angiopathies (1)  ·  Diabetic Neuropathies (1)  ·  Endocrine System Diseases (1)  ·  Foot Ulcer (1)  ·  Glucose Metabolism Disorders (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leg Ulcer (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)

Sponsors

Bayer (1)  ·  Baylor College of Medicine (1)  ·  MultiGene Vascular Systems Ltd. (1)  ·  Northwestern University (1)

Countries

United States (3)  ·  Austria (1)  ·  Belgium (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Mary McDermott, MD (1)  ·  Sam L Teichman, MD (1)

Results publications

PMID 26584888, PMID 30943782, PMID 42573020